补体因子P(CFP)重组蛋白

Recombinant Complement Factor P (CFP)

CF-P; PFC; Properdin

  • 补体因子P(CFP)重组蛋白产品包装(模拟)
  • 补体因子P(CFP)重组蛋白产品包装(模拟)
  • RPA783Mu03.jpgFigure. SDS-PAGE
  • Certificate通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号适用物种:Mus musculus (Mouse,小鼠)应用(仅供研究使用,不用于临床诊断!)
RPA783Mu01补体因子P(CFP)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA783Mu03补体因子P(CFP)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA783Mu02补体因子P(CFP)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA783Mu02补体因子P(CFP)多克隆抗体WB; IHC; ICC; IP.
PAA783Mu01补体因子P(CFP)多克隆抗体WB; IHC; ICC; IP.
LAA783Mu71补体因子P(CFP)多克隆抗体(生物素标记)WB; IHC; ICC.
SEA783Mu补体因子P(CFP)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.

参考文献

杂志参考文献
BMC NephrologyComplement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis[BioMed: 14712369]
LupusComplement alternative pathway activation associated with pulmonary hypertension in lupus nephritis patients[Pubmed: 31296141]
CLINICAL AND EXPERIMENTAL IMMUNOLOGYThe alternative complement pathway in ANCA‐associated vasculitis: further evidence and a meta‐analysis[Pubmed: 32691878]
Am J Med SciLupus Nephritis with Obvious IgA deposits in the Kidneys[34332968]